REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mercurypharm S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Health and Personal Care Stores | Pharmacies and Drug Stores | Other Direct Selling Establishments
Full name: Mercurypharm S.A. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Mercurypharm S.A. is a company in Ecuador, with a head office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on September 24, 2021. 3 (2023) employees currently work for Mercurypharm S.A.. The company’s latest financial report indicates a net sales revenue increase of 624.64% in 2023. Its total assets grew by 462.88% over the same period. The net profit margin of Mercurypharm S.A. increased by 66.51% in 2023.

Headquarters
Av. Juan Tanca Marengo 804, Edificio 100 Business Center Bldg.
Guayaquil; Guayas;

Contact Details: Purchase the Mercurypharm S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Mercurypharm S.A. report to view the information.
Outstanding Shares:
Purchase the Mercurypharm S.A. report to view the information.
Registered Capital:
Purchase the Mercurypharm S.A. report to view the information.
Incorporation Date:
September 24, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.94%
Purchase this report to view the information.
0.06%
Company Performance
Financial values in the chart are available after Mercurypharm S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
624.64%▲
Total operating revenue
611.68%▲
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
11708.25%▲
Total assets
462.88%▲
Total equity
4682.09%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
66.51%▲
Return on Equity (ROE)
58.26%▲
Quick Ratio
-4.25%▼
Cash Ratio
0.27%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo